ROUSSELOT SAS   Report issue

For profit Phase 1
Founded: Courbevoie France (1891)
Status: No NME R&D (1891)

Organization Overview

First Clinical Trial
2010
NCT01293045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Nealth Sarl | Rousselot BVBA

Active Ingredients

Drugs in Phase 1 Trials (3)

cellulose (2 trials)

collagen (6 trials)

wheat (1 trial)

Drugs in Other Trials (2)

maltodextrin (2 trials)

whey protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoporosis (Phase 1)

Overweight (Phase 1)

Weight Loss (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 9
  • # of Trial APIs: 5